Requip (ropinirole) is the SECOND new drug for Parkinson's

    You now have a new option for treating Parkinson's.

    Requip (ropinirole) is the SECOND new drug for Parkinson's to hit the market this year.

    The first one, Mirapex (pramipexole), was approved in July.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote